Stages: A Deep Dive into How Cancer Staging Came About and a Breakdown of What They Mean

When I first received my cancer staging, the flurry of letters and numbers seemed like an indecipherable code. Each symbol represented critical information about my condition, but without understanding what they meant, I felt lost. This is a common experience for many who are first confronted with their cancer diagnosis and staging. In my quest for clarity, I turned to ChatGPT, an AI developed by OpenAI, which helped demystify the medical jargon. This encounter didn't just enlighten me—it also piqued my curiosity. As I delved deeper into the subject of cancer staging, I realized the power of this knowledge, especially in explaining my situation to loved ones. Let’s take a closer look at the origins of cancer staging, the brilliant minds behind its development, and the various systems in use today.

The Roots of Cancer Staging: From Ancient Observations to Modern Systems

Cancer staging began with the observations of Hippocrates in ancient Greece, who used the terms "carcinos" and "carcinoma" (derived from "crab") to describe tumors. This was due to the tumor's vein patterns resembling a crab's limbs. Later, Galen of Rome built upon this, linking cancer to an excess of black bile. These early theories shaped medical thinking for centuries, though they lacked the precision of modern science.

In the 20th century, the structured approach to cancer staging took shape with Cuthbert Dukes' introduction of his staging system in 1932, specifically for colorectal cancer. This system categorized the progression of cancer based on how deeply it had penetrated the bowel and whether it had spread to lymph nodes. Soon after, in 1968, Pierre Denoix—probably with a lit cigarette in hand—developed the TNM system—Tumor, Node, Metastasis—which provided a more detailed and standardized framework used globally today.

Technological and Collaborative Enhancements in Cancer Staging

As the field of cancer staging evolved, the role of pathological studies became crucial. By the 19th century, pathologists recognized the importance of observing tumor cells' appearance and behavior, fostering the initial classification efforts based on cellular pathology. This period marked a pivotal shift from theoretical science to practical, empirical applications in understanding cancer.

The advent of radiology, especially with the introduction of X-rays in 1895, revolutionized cancer staging. Imaging technologies allowed for non-invasive insights into the internal state of the body, significantly refining the staging process by revealing tumor size, location, and spread without needing surgery.

Collaboration also played a key role in the evolution of cancer staging. The formation of international bodies like the International Union Against Cancer (UICC) standardized the TNM system globally, ensuring that staging systems were universally applicable and continuously updated based on the latest scientific discoveries.

Recent technological advancements, such as digital imaging and computer algorithms, have further refined staging accuracy. Today, the integration of artificial intelligence and machine learning in analyzing imaging data and predicting patient outcomes points to the future direction of cancer staging.

Stages 1-4 and What A, B, C Mean in Cancer Staging

Cancer staging is crucial for determining the best treatment approach and for understanding prognosis. Here’s a breakdown:

  • Stage 1: The cancer is small and confined to its origin.

  • Stage 2: The cancer is larger and may have spread to nearby tissues or lymph nodes.

  • Stage 3: The cancer is even larger, with further spread to nearby tissues or more lymph nodes.

  • Stage 4: The cancer has spread to distant parts of the body (metastasized).

The sub-stages, denoted as A, B, and C, refine this further by detailing the extent of the tumor and its spread, crucial for tailoring treatment plans.

The Evolution of Diagnostic Techniques: From Biopsy to PET Scans

As my own journey with colon cancer unfolded, understanding the tools used to determine staging became vital. Initially, blood tests are used to look for indicators of cancer. Following this, a biopsy confirms the type of cancer and its aggressiveness. Advanced imaging techniques like MRI, CT scans, and PET scans map the location and spread of cancer, enhancing the accuracy of staging significantly.

Looking Ahead: The Future of Cancer Staging

Modern cancer staging continues to evolve, integrating genetic and molecular markers that promise even more personalized treatment strategies. This ongoing advancement not only helps in tailoring treatments better but also in improving outcomes for patients worldwide. I had no genetic or molecular markers for my colon cancer. Prior to my diagnoses I had a second aunt who had breast cancer, but no one else in my family on either side had a history of cancer. Since my diagnoses, my cousin on my moms side was just diagnosed with Angioimmunoblastic T-cell lymphoma which wasn’t genetic, but thought to be because of his time serving in the military.

Conclusion: Empowerment Through Knowledge

Understanding my cancer staging transformed a daunting diagnosis into a navigable map of my health challenge, easing my anxiety and enabling my loved ones to support me effectively. By sharing this journey and the insights I've gained, I hope to empower others facing similar battles. Knowledge is not just power—it's also peace.

A blog post by Rachel Smak on grief, loss, and lessons from stage 3C rectal cancer

Rachel Smak

College and corporate drop out, I picked up a camera and pursued my curiosity for storytelling as a Minneapolis born-and-raised wedding photographer turned branding and small business educator. I love travel, potatoes, (in ANY form) and decorating my apartment as if I hosted my own HGTV show.  

https://www.rachelsmak.com
Previous
Previous

Update: I’m Still Not Dead. But I Am Different.

Next
Next

Texts I Got After Telling People I Had Cancer